Kane Biotech Announces First Quarter 2026 Financial Results
WINNIPEG, Manitoba, May 28, 2026 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its first quarter 2026 financial results. First Quarter 2026 Financial Highlights: Total revenue for the three months ended March 31, 2026 was $43,218 compared to $412,513 in three months ended March 31, 2025. Revenue in […]
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.